Randomized Double-Blind Trial on Safety and Efficacy of Nanordica Advanced Antibacterial Wound Dressing for Diabetic Foot Ulcer
NCT: NCT06667752 · ACTIVE_NOT_RECRUITING
광고
NCT IDNCT06667752
상태ACTIVE_NOT_RECRUITING
시작일2024-10-17
완료2026-12-31
SponsorNanordica Medical OU (INDUSTRY)
First posted
Last updated
간략 요약
This clinical trial evaluates the safety and efficacy of the Nanordica Advanced Antibacterial Wound Dressing (AAWD) in patients suffering from diabetic foot ulcers. At least 136 participants will be randomly allocated to be treated either with AAWD or Aquacel Ag+ Extra wound dressing for a 4-week active phase (intervention) followed by an 8-week standard of care period.
공식 출처
ClinicalTrials.gov에서 보기 →데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.